XPeng Begins Robotaxi Employee Testing; Milestone But No Near-Term Catalyst

What happened

XPeng has initiated employee testing of its Robotaxi platform, just eight months after unveiling the initiative at AI Day 2025, positioning autonomous driving as a key step toward Physical AI. The DeepValue master report rates XPeng a WAIT, emphasizing that near-term value depends on Q2 2026 deliveries hitting 100,000–106,000 units and the GX SUV ramping to meaningful monthly volume. Robotaxi testing is a long-term narrative boost but carries no near-term revenue impact and does not alter the critical checkpoints of delivery mix and vehicle margin stability. The company's Q1 2026 vehicle margin slipped to 12.1% from 13.0% in Q4 2025, and MONA M03 comprised ~44% of May deliveries, underscoring that volume growth remains skewed toward low-ASP models. Until XPeng demonstrates that the GX ramp and broader mix improvement can stabilize margins, the stock remains a wait-and-see proposition.

Implication

The Robotaxi employee testing is a positive signal for XPeng's autonomous driving ambitions, but it does not change the investment thesis over the next 3–6 months. The stock's re-rating depends on hard evidence of Q2 delivery guidance achievement (100k–106k units) and a steep GX delivery ramp in June–July 2026, while vehicle margin must hold near 12.1% or improve. Until those checkpoints are met, the stock remains a WAIT, with attractive entry at $12 and trim above $20. The Robotaxi news could boost sentiment temporarily, but it is not a fundamental catalyst for near-term earnings.

Thesis delta

Robotaxi testing is a positive long-term signal but does not change the 3-6 month thesis which hinges on Q2 delivery execution and GX ramp. The stock remains a WAIT until those hard checkpoints are met.